COMMUNIQUÉS West-GlobeNewswire

Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
18/02/2025
This marks the second BTD for petosemtamab in HNSCC UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, [...]
Lighthouse Autism Center Expands Diagnostic Testing Services to Shorten Wait Times and Increase Access to Care
18/02/2025
MISHAWAKA, Ind., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lighthouse Autism Center is proud to announce the expansion of its diagnostic testing services, offering more appointments and shorter wait times for families seeking [...]
Arcutis to Present at the TD Cowen 45th Annual Health Care Conference
18/02/2025
WESTLAKE VILLAGE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Sotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release Date
18/02/2025
CLEVELAND, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare [...]
Aptose Announces Reverse Share Split
18/02/2025
SAN DIEGO and TORONTO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based [...]
Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)
18/02/2025
TEL AVIV, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will conduct a conference call and live webcast at 8 am E.T. on Monday, February 24, [...]
Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression
18/02/2025
Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS total score compared to placebo SPN-820 was well-tolerated with few adverse [...]
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for GOMEKLI™ (mirdametinib), Manufactured By SpringWorks Therapeutics
17/02/2025
LOUISVILLE, Ky., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent specialty pharmacy, has been selected as a national pharmacy partner by SpringWorks Therapeutics, Inc. for GOMEKLI ( [...]
Galapagos receives transparency notification and 13D filing from Tang Capital
17/02/2025
Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification and 13D filing from Tang Capital. Pursuant to Belgian transparency [...]
RAMSAY SANTE : closing repricing 250217
17/02/2025
PRESS RELEASE Paris, 17 February 2025 Ramsay Santé has successfully repriced its €1,025m TLB4 and extended for 2 years its €425m TLB3, both merged in a new single Term Loan B5 Ramsay Santé today announced that it has [...]
RAMSAY SANTE : closing repricing 17 février 2025
17/02/2025
COMMUNIQUÉ DE PRESSE Paris, le 17 février 2025 Ramsay Santé réalise avec succès le repricing de sa tranche TLB 4 de €1,025m et étend de 2 ans sa tranche TLB3 de €425m, toutes deux fusionnées dans une nouvelle tranche [...]
Virbac : Declaration of the number of shares and voting rights 01/2025
17/02/2025
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Virbac : Déclaration d'actions et de droits de vote 01/2025
17/02/2025
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Legend Senior Living® Expands Presence in Oklahoma With New Residence in Edmond
17/02/2025
OKLAHOMA CITY, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living ® , a premier senior living provider headquartered in Wichita, KS, has expanded its presence in Oklahoma with the acquisition and operation of [...]
PracticeLink Launches PRO Marketing Services to Help Healthcare Employers Meet Hiring Needs
17/02/2025
Innovative end-to-end recruitment marketing initiative provides customized approach, targeted reach and data-driven results for healthcare organizations ST. LOUIS and HINTON, West Virginia, Feb. 17, 2025 (GLOBE NEWSWIRE [...]
Enlitic and GE HealthCare to Collaborate to Redefine Imaging Data Migration and Cloud Solutions for Enterprise Imaging
17/02/2025
FORT COLLINS, Colo., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Enlitic, Inc. , (ASX:ENL) a leader in healthcare imaging data solutions, and its subsidiary Laitek , announces a collaboration with GE HealthCare , a leading global [...]
Targeted Genomics Receives FDA Clearance for First Direct-to-Consumer Celiac Disease Genetic Health Risk Test
17/02/2025
IRVINE, Calif., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, a family owned genetic testing Company, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its Direct-to- [...]
Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11%
17/02/2025
Company expects to report Q3-FY25 revenue growth of 22% from the corresponding prior year quarter to $3.6 million – an 11% increase sequentially from the immediately preceding quarter Management continues to drive [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
17/02/2025
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS 17 FEBRUARY 2025 at 15.15 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

Pages